Friday, October 13, 2017 9:42:21 AM
REUTERS 8:35 AM ET 10/13/2017
Symbol Last Price Change
RVXCF 1.4184up 0 (0%)
QUOTES AS OF 02:52:01 PM ET 10/12/2017
Oct 13 (Reuters) - Resverlogix Corp(RVXCF):
* Resverlogix(RVXCF) announces $87 million private placement with shenzhen hepalink
* Resverlogix Corp(RVXCF) - ?net proceeds of offering will primarily be used to repay company's $68.8 million secured loan which matures on December 26, 2017?
* Resverlogix Corp(RVXCF) - ? private placement of 60.4 million equity units to Shenzhen Hepalink Pharmaceutical Co. Ltd. At a price of $1.44 per unit?
* Resverlogix-Proceeds will also be used to fund research,development activities for clinical trial activities related to phase 3 betonmace trial?
* Resverlogix(RVXCF) - ? placement to address co's financial difficulties by providing sufficient funds to repay loan and to satisfy short term cash requirements? Source text for Eikon: Further company coverage:
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM